Assura PLC
LSE:AGR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
37.86
47.9453
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Assura PLC
Assura PLC
Cash & Cash Equivalents
Assura PLC
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Assura PLC
LSE:AGR
|
Cash & Cash Equivalents
£35.4m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Primary Health Properties PLC
LSE:PHP
|
Cash & Cash Equivalents
£4.1m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-4%
|
|
|
Target Healthcare REIT PLC
LSE:THRL
|
Cash & Cash Equivalents
£17.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Impact Healthcare REIT PLC
LSE:IHR
|
Cash & Cash Equivalents
£9.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
L
|
Life Science REIT PLC
LSE:LABS
|
Cash & Cash Equivalents
£14.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Assura PLC
Glance View
Assura Plc is a healthcare real estate investment trust, which engages in the provision of property solutions. The company is headquartered in Warrington, Cheshire and currently employs 68 full-time employees. The company went IPO on 2015-01-28. The firm is a primary care property investor and developer. The firm is specialized in the development of, investment in and management of, a portfolio of primary care, community, diagnostic and treatment buildings across the United Kingdom. The Group owns and manages a portfolio of 625 modern primary healthcare properties. The firm's subsidiaries include Apollo Capital Projects Development Ltd, Assura Trellech Ltd, Newton Healthcare Ltd, Assura (SC1) Ltd, BHE (Heartlands) Ltd, Park Medical Services Ltd, Assura (SC2) Ltd, BHE (St James) Ltd, Pentagon HS Ltd, Assura Aspire Ltd, Bicester HC Developments Ltd, Prime Hereford Hub Ltd, Assura Aspire UK Ltd, Cheltenham Family Health Care Centre Ltd, Prospect Medical (Malvern) Ltd, Assura Development Hub Ltd, Community Ventures Windmill Ltd, Ridge Medical Ltd, Assura GHC Ltd, Donnington Healthcare Ltd and Shotfield Development Business Partnership Ltd.
See Also
What is Assura PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
35.4m
GBP
Based on the financial report for Mar 31, 2024, Assura PLC's Cash & Cash Equivalents amounts to 35.4m GBP.
What is Assura PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
14%
Over the last year, the Cash & Cash Equivalents growth was -70%. The average annual Cash & Cash Equivalents growth rates for Assura PLC have been -9% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
